Financial Performance for US Ambulatory Surgery Centers: Revenue Per Case, Payer Mix, and Operating Efficiency

Why Ambulatory Surgery Centers Are One of Healthcare Most Attractive Business Models#

US ambulatory surgery centers perform over 25 million procedures annually and generate approximately $40 billion in revenue. The ASC business model is financially attractive for several reasons: lower overhead than hospital operating rooms, physician co-ownership aligning clinical and business incentives, and CMS reimbursement for outpatient procedures that has expanded significantly over the past decade as procedures previously requiring inpatient stays shift to outpatient settings. ASCs in the right specialties — orthopedics, ophthalmology, gastroenterology, pain management — achieve EBITDA margins of 20 to 35%, making them among the most profitable healthcare facilities in the US.

Revenue Per Case: The Primary Financial Metric#

Revenue per case — net collections divided by total cases performed — is the most important financial metric for US ambulatory surgery centers. It varies enormously by specialty and procedure mix: ophthalmology cases (cataract surgery) may generate $800 to $1,500 in ASC reimbursement; orthopedic procedures like ACL reconstruction or shoulder arthroscopy generate $3,000 to $7,000; and complex spine procedures, now increasingly approved for ASC settings, can exceed $10,000. Tracking revenue per case by surgeon and by procedure type monthly reveals which cases and which physicians are driving facility economics and which relationships deserve prioritization in scheduling and OR time allocation.

Payer Mix: The Revenue Quality Determinant#

Payer mix is the primary determinant of revenue quality at US ASCs. Medicare and commercial insurance are the primary payers for most outpatient surgical procedures; Medicaid reimbursement for surgical procedures is typically below cost and most ASCs limit Medicaid volume strategically. Workers compensation cases often reimburse at rates above commercial insurance. The most profitable payer mix for US ASCs combines commercial insurance (typically 50 to 60% of cases), Medicare (25 to 35%), workers compensation (5 to 15%), and minimal Medicaid exposure. Tracking payer mix by specialty and monitoring shifts in commercial insurance concentration alerts ASC administrators to revenue quality changes months before they appear in monthly financial statements.

Cost Per Case: Controlling Surgical Supply and Implant Cost#

Surgical supply and implant cost is the most significant variable cost at US orthopedic and spine ASCs, often representing 30 to 50% of net revenue for implant-intensive procedures. Implant cost standardization — working with physician partners to establish standardized implant preference cards, consolidating vendor relationships for volume pricing, and eliminating unnecessary preference card items — is the single highest-impact cost reduction initiative available to most orthopedic ASCs. Centers that standardize implants across their physician group can reduce implant cost per case by 15 to 30% without compromising patient outcomes, directly improving case-level margin.

OR Utilization: Maximizing Revenue From Fixed Infrastructure#

Operating room utilization — the percentage of available OR time that is used for revenue-generating procedures — determines how efficiently a US ASC converts its fixed facility cost into revenue. Well-run ASCs target 75 to 85% OR utilization during scheduled hours. Below 65% indicates either insufficient case volume for current OR capacity, scheduling inefficiency, or case cancellation rates above industry norms. Above 90% utilization without additional OR capacity creates scheduling bottlenecks that frustrate surgeon partners and ultimately drive volume to competitor facilities. Tracking utilization by OR, by day of week, and by surgical specialty reveals where capacity is being underused and where demand is building.

Case Mix and Certificate of Need Implications#

US ASCs operate under varying regulatory environments — 36 states require a Certificate of Need (CON) for new ASC development, limiting competitive supply. In CON states, existing ASCs face less competitive pressure from new entrants. ASC case mix evolves as CMS continues expanding the list of procedures approved for outpatient settings, most recently including total joint replacements and certain cardiac procedures. Centers that can perform these higher-acuity procedures are positioned for revenue per case growth as surgeon partners develop the experience and as payer approval becomes routine. Monitoring CMS proposed rule changes and competitor capability investments provides early signal of case mix shifts that will affect facility economics.

Partnership and Governance: Physician Co-Ownership Dynamics#

Most US ASCs operate under physician co-ownership models where surgeon partners hold ownership interests and share in facility profits. This alignment creates strong incentives for volume commitment and cost discipline — physician-owners who benefit from facility profitability make better implant selection and scheduling decisions than those with no financial stake. Managing partner distributions, adding new physician partners, and handling partner departures are governance events with significant financial implications. ASC administrators should track distributions per ownership unit quarterly and model the impact of partnership changes on facility revenue stability before executing any ownership structure changes.